# Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

> **NCT02598219** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Centre Oscar Lambret** · enrollment: 262 (actual)

## Conditions studied

- Non Endometrioid Carcinoma
- Endometrioid Carcinoma

## Interventions

- **DRUG:** Pre-operative SN mapping with radionucleide
- **DRUG:** Intra-operative SN mapping with patent V blue dye
- **DRUG:** Intra-operative SN mapping with indocyanin green
- **PROCEDURE:** Full bilateral laparoscopic lymphadenectomy and Hysterectomy
- **PROCEDURE:** Current initial staging protocols

## Key facts

- **NCT ID:** NCT02598219
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-11
- **Primary completion:** 2024-10
- **Final completion:** 2027-10
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02598219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02598219, "Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02598219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*